Epithelial basement membrane dystrophy (EBMD), also known as map-dot-fingerprint, Cogan microcystic epithelial, or anterior basement membrane dystrophy, is a common disorder of the anterior cornea that may affect at least 2% of the general population.
1 It is characterized by any combination of maplike geographic patterns, dot patterns, or fingerprint lines in the corneal epithelium, arising due to defective adhesion between the epithelial basement membrane and the collagen of Bowman's layer.
1 These lesions can change in appearance, numbers, and locations over a period of time and can be difficult to detect on routine examination. EBMD has been described as an autosomal dominant trait in several families, but is more commonly found in patients with no known familial inheritance.
2,3 Corneal dystrophies are by definition hereditary; therefore, the term dystrophy is not accurate unless inheritance can be confirmed.
Although most cases of EBMD are asymptomatic, in approximately 10%, symptoms of painful recurrent corneal erosions or degraded vision are present
1 and require clinical attention. Approximately 10% of these patients, however, are unresponsive to conservative treatment measures (such as lubricant ointments and therapeutic contact lenses) and are considered for surgical intervention.
4 In recent years, excimer laser phototherapeutic keratectomy (PTK) has become an increasingly popular surgical option for the treatment of EBMD, due to successful resolution of symptoms documented in a number of studies.
4–8
In a previous study, we evaluated the outcome of PTK treatment of EBMD and examined clinical and morphological signs of recurrence of the dystrophy after PTK treatment.
8 In that study, it was found that PTK improved vision in patients and reduced the severity of phenotypic changes in the epithelium, likely due to renewed epithelial adhesion complexes after complete surgical removal of the original basement membane.
8 Despite success of the treatment, the pathogenesis of EBMD is largely unknown, and a number of questions concerning the dystrophy and its treatment remain. For example, the corneal subbasal epithelial nerve plexus that gives rise to epithelial innervation
9–11 is located precisely at the interface of the basement membrane and Bowman's layer, an interface that is pathologic in EBMD. How is the epithelial innervation affected by EBMD? We previously reported a partial recovery of subbasal nerves up to 8 months after PTK,
12 but it is unknown if the treatment influences innervation in the long term, and if so, is the influence a positive or negative one? It has also been shown in a previous prospective study that the density of epithelial cells can be affected by PTK.
12 It is also unknown whether these changes persist in the long term. Furthermore, localized enlargement, deformation, and displacement of epithelial wing cells has been previously observed in corneas affected by EBMD by in vivo confocal microscopy (IVCM).
8 It is unknown whether these perturbations significantly reduce the epithelial wing cell density.
To address these questions, we undertook a detailed analysis of IVCM images of corneal subbasal nerves and epithelial wing cells in the EBMD patient group examined in our previous
8 cross-sectional study. To allow for comparisons, a control group consisting of 40 healthy volunteers was additionally recruited and examined. Finally, we report a new fully automated technique for cell identification and quantitative analysis in IVCM images, which is based on freely available public-domain software. The automated technique is compared with an earlier manual method of analysis.
12
The specific hypotheses we wished to address in this study were the following: